Pediatric Imaging

Why Is Arteriography the Next Step for Pediatric Intraparenchymal Hemorrhage of Unknown Cause?

·
Why Is Arteriography the Next Step for Pediatric Intraparenchymal Hemorrhage of Unknown Cause?

A 7-year-old presents to the emergency department with a sudden, severe headache and new-onset left-sided weakness. A non-contrast head CT confirms the clinical suspicion of an acute bleed, revealing a right frontal intraparenchymal hematoma. There is no history of trauma, and the child has no known coagulopathy. The initial scan has identified the hemorrhage, but not its cause. The critical question for the admitting pediatric neurology and neurosurgery teams is how to definitively identify the underlying etiology to guide treatment and prevent re-bleeding. This article details the clinical workflow for this exact scenario, explaining why the American College of Radiology (ACR) rates cervicocerebral arteriography as Usually Appropriate for the next diagnostic step.

Who Fits This Clinical Scenario?

This diagnostic workflow is intended for a pediatric patient who has a nontraumatic intraparenchymal hemorrhage (a hematoma within the brain tissue) that has been identified on a prior imaging study, typically a CT or MRI. The key criterion is that the etiology of the hemorrhage remains unknown after this initial imaging. This guide helps clinicians determine the most effective next study to uncover the underlying cause.

This scenario is distinct from several related clinical presentations that require different imaging pathways. This guidance does not apply if:

  • The hemorrhage is clearly traumatic. In cases of known head injury, the diagnostic focus is on the extent of injury, not an underlying vascular anomaly.
  • The hemorrhage is primarily subarachnoid. A nontraumatic subarachnoid hemorrhage (SAH) has a different differential diagnosis, most commonly a ruptured aneurysm, and follows a separate ACR imaging variant.
  • A clear cause is already identified. If the initial CT or MRI shows a definite tumor, large vascular malformation, or evidence of hemorrhagic conversion of an ischemic stroke, the workup proceeds down those specific pathways.
  • The patient presents with signs of acute stroke without hemorrhage. The workup for suspected pediatric ischemic stroke is a distinct clinical problem with its own set of imaging recommendations.

Correctly identifying that your patient fits this specific scenario—a child with a spontaneous, unexplained intraparenchymal bleed—is crucial for selecting the most diagnostically powerful next step.

What Diagnoses Are You Working Up in This Scenario?

When a child has a spontaneous intraparenchymal hemorrhage, the primary goal of subsequent imaging is to identify a structural vascular lesion that is amenable to treatment. The differential diagnosis is focused on lesions known to have a high risk of rupture and re-hemorrhage.

Arteriovenous Malformation (AVM) is the most common cause of spontaneous intraparenchymal hemorrhage in children. An AVM is a tangle of abnormal blood vessels connecting arteries and veins in the brain, bypassing the normal capillary system. These high-flow, high-pressure lesions have fragile vessel walls prone to rupture. Identifying the AVM’s architecture—its feeding arteries, nidus (the core tangle), and draining veins—is essential for planning neurosurgical or endovascular treatment.

Cerebral Aneurysm, while more common in adults, can also occur in children and present with intraparenchymal hemorrhage, often in combination with subarachnoid hemorrhage. These saccular outpouchings from an artery wall can rupture, causing devastating bleeding. They are often located at vessel bifurcations and require precise localization for clipping or coiling.

Cavernous Malformation (Cavernoma) is a less common but important cause. These are clusters of abnormal, thin-walled blood vessels that create “caverns” filled with slow-moving blood. They are low-flow lesions and are often angiographically occult, meaning they may not be visible on conventional arteriography. MRI, particularly with susceptibility-weighted sequences, is the most sensitive modality for their detection.

Other, rarer causes include dural arteriovenous fistulas (dAVF), where there is an abnormal connection between an artery and a vein in the dura mater, and non-structural causes like vasculitis or moyamoya disease, which can lead to hemorrhage from fragile collateral vessels.

Why Is Cervicocerebral Arteriography the Recommended Study for This Presentation?

For a child with an unexplained intraparenchymal hemorrhage, cervicocerebral arteriography—also known as digital subtraction angiography (DSA)—is rated as Usually Appropriate by the ACR. It is considered the gold standard for evaluating the cerebral vasculature and identifying the underlying cause of the bleed.

The primary advantage of arteriography is its ability to provide high-resolution, dynamic information about blood flow. Unlike static images from CT or MRI, arteriography visualizes the passage of contrast through the arteries, into a potential lesion, and out through the veins in real-time. This is critical for definitively diagnosing and characterizing high-flow lesions like AVMs and dAVFs. It can precisely map the feeding arteries and draining veins, information that is indispensable for planning endovascular embolization or surgical resection.

While arteriography is the top-rated procedure, several non-invasive alternatives are also considered Usually Appropriate and play a vital role:

  • CTA Head with IV Contrast and MRA Head without IV Contrast are excellent non-invasive first-line options, especially if arteriography is not immediately available or if the patient’s clinical status is a concern. They can often identify larger AVMs, aneurysms, or other vascular anomalies. However, they may miss smaller or more subtle lesions, and they lack the dynamic flow information of DSA.
  • MRI Head without and with IV Contrast is also Usually Appropriate. Its strength lies in characterizing the hematoma itself and identifying associated abnormalities. It is particularly sensitive for detecting cavernous malformations, which are often not visible on arteriography.

So why is arteriography often the definitive test? A negative CTA or MRA does not fully exclude a vascular cause. A small AVM or dAVF might be obscured by the hematoma on non-invasive imaging. Arteriography has superior spatial and temporal resolution, allowing it to detect subtle shunting or tiny feeding vessels that other modalities miss. The procedure involves an invasive arterial puncture and carries a pediatric radiation dose of 3-10 mSv (☢☢☢☢), but its high diagnostic yield often justifies these risks in this high-stakes clinical scenario.

What’s Next After Cervicocerebral Arteriography? Downstream Workflow

The results of the cervicocerebral arteriogram will directly guide the subsequent clinical and therapeutic pathway. The decision tree branches based on whether a treatable lesion is found.

If the study is positive for a vascular lesion (e.g., AVM, aneurysm, dAVF):
The immediate next step is a multidisciplinary consultation with pediatric neurosurgery and interventional neuroradiology. The detailed vascular map provided by the arteriogram is used to plan treatment, which may include endovascular embolization to reduce blood flow to the lesion, stereotactic radiosurgery to obliterate it over time, or direct surgical resection. The choice of therapy depends on the lesion’s size, location, and vascular anatomy.

If the study is negative for a vascular lesion:
A negative arteriogram is reassuring but does not end the workup. The hematoma itself can compress and obscure a small underlying lesion. In this situation, the standard of care is often to obtain a follow-up MRI with contrast and susceptibility-weighted imaging (SWI) in 3 to 6 months, after the hematoma has had time to resolve. This delayed imaging may unmask a previously hidden cavernous malformation or a small, thrombosed AVM. If this follow-up MRI is also negative, a repeat arteriogram may be considered, as some lesions can recanalize.

If the study is indeterminate:
Occasionally, findings may be ambiguous, showing subtle vascular staining or an early draining vein without a clear nidus. This can occur with very small AVMs or in the presence of significant mass effect from the hematoma. In these cases, the decision-making relies heavily on a multidisciplinary team discussion. The plan may involve close surveillance with serial MRI and a low threshold to repeat the arteriogram after the hematoma has resolved.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for pediatric intraparenchymal hemorrhage requires careful attention to detail to avoid common diagnostic errors. Here are several pitfalls to be aware of:

  • Stopping the workup too early: A negative non-invasive study like a CTA or MRA is not sufficient to rule out an underlying vascular lesion. Failing to proceed to arteriography or to schedule follow-up imaging can lead to a missed diagnosis and risk of re-hemorrhage.
  • Misinterpreting reactive changes: The brain’s response to a hematoma can include reactive hyperemia or luxury perfusion, which can be mistaken for a vascular malformation on less specific imaging. Arteriography helps differentiate these reactive changes from a true underlying lesion.
  • Ignoring the need for delayed imaging: The mass effect and edema from an acute hematoma can obscure the causative lesion. It is a critical error to not plan for follow-up imaging after the hematoma has resolved if the initial workup is negative.
  • Inadequate sedation or anesthesia: Pediatric arteriography requires deep sedation or general anesthesia to prevent motion, which can degrade image quality and compromise diagnostic accuracy. This must be performed by a team experienced in pediatric anesthesia.

If the initial workup is negative and the clinical suspicion for a vascular lesion remains high, or if the findings are complex, escalation to a high-volume pediatric neurovascular center for a second opinion or further management is the appropriate next step.

Related ACR Topics and Tools

This article covers one specific scenario within the broader topic of pediatric cerebrovascular disease. For a comprehensive overview of related presentations, from acute stroke to subarachnoid hemorrhage, please consult the parent topic hub article. Additionally, several GigHz tools can support your clinical decision-making process.

Frequently Asked Questions

Why is invasive arteriography necessary if a high-quality CTA or MRA was already performed and was negative?

While CTA and MRA are excellent non-invasive screening tools, they can miss small or low-flow vascular lesions, especially when obscured by the mass effect of a hematoma. Cervicocerebral arteriography (DSA) offers superior spatial and temporal resolution, providing real-time blood flow information that can reveal subtle arteriovenous shunting or tiny aneurysms missed by other modalities. It remains the gold standard for a definitive diagnosis in this setting.

What if the child is too clinically unstable to undergo a lengthy arteriography procedure?

Patient stability is paramount. If a child is unstable, the immediate priority is medical and neurocritical care stabilization. A CTA head with IV contrast can be a rapid and valuable alternative to obtain vascular information quickly. It is also rated as ‘Usually Appropriate’ by the ACR. Once the patient is stabilized, a formal arteriogram can be planned if the CTA was non-diagnostic or if more detailed information is needed for treatment planning.

If the arteriogram is negative, what is the risk of a repeat hemorrhage?

The risk of re-bleeding after a negative initial workup is not zero. A small lesion may have been obscured by the initial hematoma. This is why follow-up imaging, typically an MRI at 3-6 months, is critical. If a lesion like a cavernous malformation or a small AVM is unmasked on follow-up, the risk can be properly stratified. If the entire workup, including delayed imaging, is negative, the cause is deemed cryptogenic, and the re-bleeding risk is considered low, though not completely eliminated.

Is MRI or arteriography better for detecting a cavernous malformation?

MRI is far superior for detecting cavernous malformations. These are low-flow lesions that are often ‘angiographically occult,’ meaning they do not show up on an arteriogram. MRI sequences like susceptibility-weighted imaging (SWI) are extremely sensitive to the hemosiderin deposits characteristic of cavernomas. This is why a comprehensive workup often involves both arteriography (to rule out high-flow lesions like AVMs) and MRI (to rule out low-flow lesions like cavernomas).

Are there any alternatives to a second arteriogram if the first one is negative but suspicion remains high?

If the initial arteriogram and follow-up MRI are both negative, the decision for a repeat arteriogram is made on a case-by-case basis, often in a multidisciplinary conference. Factors include the location and size of the initial hemorrhage and the patient’s clinical course. There are no better alternatives for detecting a subtle, high-flow vascular lesion. The repeat study is intended to see if a previously thrombosed or compressed lesion has become visible after the initial clot has fully resolved.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026